Skip to main content
. Author manuscript; available in PMC: 2019 May 13.
Published in final edited form as: Enzymes. 2013 Aug 8;33(Pt A):117–146. doi: 10.1016/B978-0-12-416749-0.00006-3

Figure 6.6.

Figure 6.6

Effects of EHop-016 on Rac signaling. EHop-016 inhibits the Vav2/Rac interaction, Rac and PAK activities, lamellipodia formation, and metastatic cancer cell migration. Thus, EHop-016 holds promise as an anticancer metastatic agent.